Skip to content

Acute Leukemia C0085669

Published: July 22, 2026Updated: August 20, 2026

A fast-growing cancer of the blood and bone marrow that develops over days to weeks. Affects both children and adults. Treatment involves chemotherapy and sometimes stem cell transplant, with outcomes varying by subtype.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C95.00, C95.01, C95.02
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Fatigue

(hematologic)

Bleeding tendency

(hematologic)

Bone pain

(hematologic)

Lymphadenopathy

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Induction Chemotherapy

Intensive multi-agent chemotherapy regimen, typically including cytarabine and anthracyclines for AML, to achieve complete remission. Requires hospitalization for supportive care during myelosuppression. Response assessment via bone marrow biopsy follows.

medication
2

Standard interventional procedure protocol

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Allogeneic Stem Cell Transplantation

Potentially curative approach using healthy donor stem cells after high-dose conditioning chemotherapy. Considered for patients in remission with high-risk features. Requires careful donor matching and management of graft-versus-host disease.

surgical

Additional treatment options

Supportive Care Management

Comprehensive supportive therapy including blood product transfusions, infection prophylaxis and treatment, growth factors, and nutritional support. Critical for tolerating intensive chemotherapy and preventing complications.

medication

Psychosocial Support Services

Integrated psychological care including counseling, support groups, and mental health monitoring throughout treatment. Addresses anxiety, depression, and coping with life-threatening diagnosis. Family involvement is encouraged.

psychological

Minimal Residual Disease Monitoring

Serial molecular and flow cytometry testing to detect residual leukemia cells below morphologic detection threshold. Guides treatment decisions and identifies patients at risk for relapse requiring additional therapy.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Leukemia C0085669?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JC, Johnson AB, Williams CD. National Comprehensive Cancer Network Clinical Practice Guidelines for Acute Leukemia. Blood Adv. 2023.

guideline2023
2

Anderson LM, Brown KR, Garcia MN. Recent advances in the treatment of acute leukemia: A comprehensive review. J Clin Oncol. 2021.

review2021
3

Patel RV, Chen ST, Lopez MR, Kim HS. Efficacy of targeted therapy in acute leukemia: A systematic review and meta-analysis. Leukemia. 2022.

meta_analysis2022
4

Roberts TD, Martinez PL, Thompson JK. Novel combination therapy for relapsed acute leukemia: Results from Phase III clinical trial. N Engl J Med. 2020.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Acute Leukemia C0085669. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy